Biointelli Predict™ · The New Revenue Standard
Scientific Signal Intelligence
Biointelli Predict™ tracks grants, publications, conferences, and funding activity across 23 live sources — and turns the rate of change into a single Delta score that tells your team who to call today, 6–18 months before the purchase shows up anywhere else.
Scientific Signal Intelligence in life sciences refers to the ability to detect early indicators of research and commercial momentum across biotech companies, laboratories, and scientific organizations.
As an emerging category, it shifts how life science teams identify opportunity — from static views of accounts to a dynamic understanding of what is changing in the market.
Rather than relying on contact databases or existing account lists, Scientific Signal Intelligence focuses on signal movement — and the Delta (change) in those signals over time — to determine when an organization is entering a phase of acceleration.
These signals include:
Traditional platforms focus on who exists — contact records, known accounts, and historical data. Scientific Signal Intelligence focuses on what is changing — identifying organizations that are actively gaining momentum.
BioIntelli Predict™ defines this category by structuring and analyzing signal Delta across multiple domains to identify:
This enables life science teams to move from static prospecting to timing-based intelligence, focusing on the accounts that matter most right now.
As this category continues to develop, BioIntelli Predict™ establishes a reference model for how Scientific Signal Intelligence is defined and applied in life science commercial workflows. Learn more on the Scientific Signal Intelligence supporting page.
Scientific Signal Intelligence isn't about what a lab has done — it's about how fast their momentum is building right now. Rate of change is the leading commercial indicator that every other data product misses entirely.
Predict scores five live signal dimensions — grants, publications, patents, clinical trials, and conference activity — weighting each by velocity and recency. The result is a single 0–1 Delta score per account. High Delta means commercial momentum is accelerating. It's the difference between a list and a ranked pipeline — and it's why Predict is now the revenue driver at the center of Biointelli's platform.
Biointelli Predict™ is built on Scientific Signal Intelligence — a proprietary methodology that aggregates real-time activity from 23 global sources and converts it into ranked, actionable pipeline your team can work today.
SSI surfaces emerging opportunities 6–18 months before they appear in your CRM. Predict tells you which labs are accelerating — not which ones already bought from someone else.
23 live sources — NIH, NSF, UKRI, CORDIS, EU Horizon, PubMed, patent filings, clinical trials, and conference registrations — ingested daily into the SSI engine. No manual pulls. No stale exports.
The Predict Delta score recalculates on every new signal event. Your ranked account list updates daily — so the rep's first call every morning starts with who's accelerating right now, not six months ago.
Predict is Biointelli's primary revenue product. It converts 18 years of longitudinal scientific data into a commercial pipeline engine — scored accounts, verified contacts, and Delta-ranked priority every day.
Predict ingests live scientific activity, scores momentum with the Delta engine, and delivers ranked accounts with verified contacts — ready to work.
Real-time data from grants, publications, conferences, patents, clinical trials, and public databases — 23 sources, ingested daily.
Delta engine calculates rate-of-change momentum across five signal dimensions. Rate of change — not absolute volume — is the predictor.
Identify PIs, procurement contacts, and lab decision-makers behind each signal. Verified contact data delivered with every ranked account.
Ranked accounts and verified contacts land in your CRM or dashboard — ready for outreach, sequencing, or BioConnect AI messaging.
SSI gives your team the only signal that shows up before the purchase — not after it's already in a competitor's CRM.
Delta scores surface funded, publishing labs 6–18 months before any intent data product or CRM trigger. You're in the conversation before your competitors know it exists.
Every account your team touches is scored and ranked by Delta momentum. No gut feel, no stale lists — just a daily-updated queue of who is most likely to buy, right now.
18 years of SSI data proves it: labs that spike in grant activity, publications, and conference attendance are about to spend. Predict converts that signal directly into meetings and closed deals.
Book a demo and we'll show you which labs and companies in your segment are Delta-scoring highest — right now.
Request DemoBioIntelli Predict™ is a scientific momentum intelligence platform that forecasts emerging biotech companies and technologies by analyzing structured signals across grants, publications, patents, clinical trials, hiring, and conference activity. It enables life science commercial teams to identify high-momentum accounts, prioritize outreach, and detect early indicators of purchasing activity.
Scientific signal intelligence is an emerging approach to analyzing scientific, funding, hiring, and market signals — and the Delta (change) in those signals — to identify organizations with increasing research and commercial momentum. Within BioIntelli Predict™, this approach is used to prioritize accounts based on real-time signal movement rather than static data.
Life science companies identify newly funded research labs by tracking grant activity, funding announcements, and early-stage research expansion signals across scientific ecosystems.
Signals such as new funding, increased publication output, hiring expansion, and clinical or research activity often indicate that a lab is entering a purchasing cycle.